Abstract:Researchers have identified a novel function of acetylcholine produced by spleen fibroblastic reticular cells (FRCs) in driving autoimmune responses in systemic lupus erythematosus (SLE), according to a new study published in Cell Metabolism recently.1 The study links the neurotransmitter acetylcholine to the lipid metabolism of autoreactive B cells in the pathogenesis of SLE. Energy demands are dramatically increased in activated cells to cope with their proliferation and effector functions. Accumulating evidence suggest that germinal center (GC) B cells tend to uptake and utilize fatty acids for mitochondrial respiration. Metabolic changes including lipid metabolisms have been involved in the pathogenesis of autoimmune diseases, including SLE. “The specific roles of lipid metabolism in autoreactive B cell responses in SLE have not been determined yet,” remarks Hui Zhang, one of the responding authors of the study. The authors first showed that B cells from patients with SLE (and lupus-prone mice) preferentially rely on fatty acid oxidation (FAO) as the source of energy. Importantly, inhibition of FAO suppressed GC B cell differentiation, reduced autoantibody production, and ameliorated pathology in lupus-prone mice. Although B cells carrying B cell receptors (BCRs) with low affinity to autoantigens are prevalent in healthy individuals, the absence of high-affinity BCRs to self-antigens prevents the development of autoimmune diseases, including SLE. “High-affinity BCRs are usually generated in the GC through somatic hypermutation. B cells in the spleen receive signals from neighboring lymphocytes, dendritic cells, and stromal cells including FRCs, during GC response. The signals from the microenvironment need to be identified.” remarks Zhang. The spleen is a complex organ with multiple functions in homeostasis and immune responses. In the spleen, antigen-experienced B cells differentiate in the follicles of white pulp. FRCs are heterogeneous stromal cells that form a dense reticular network in the spleen. “Regarding the critical roles of FRCs on B cell homeostasis and follicle formation, we hypothesized that FRCs could play a role in driving autoreactive B cell responses in SLE,” explains Niansheng Yang, one of the corresponding authors. By using an elegant in vitro coculture system, the researchers demonstrated that spleen FRCs enhanced lipid oxidation in B cells through the upregulation of CD36/FABP4. Further, the researchers transferred FRCs into the spleen of lupus-prone mice, finding out that FRC injection upregulated lipid uptake into B cells and enhanced GC responses. By further analyzing the autoreactive B cells in the spleen of lupus-prone mice, they found that the number of B cells reacting with double-stranded DNA was expanded by FRC injection, which led to the development of systemic autoimmunity and immune complex deposition to the kidney. “Anatomically, most of the FRCs locate at the T cell zone of the white pulp, which is outside of GC,” says Zhang. “If FRCs are directly involved with the regulation of GC and autoreactive B cell responses in GC, FRCs should act on GC B cells by producing cues to GC B cells.” To further uncover how FRCs regulate B cells and the underlying mechanisms, the researchers screened the culture supernatant of spleen FRCs, finding out that spleen FRCs promoted B cell lipid metabolism by the production of acetylcholine. Acetylcholine reprogrammed B cell metabolism to FAO through the upregulation of CD36/FABP4. In vivo, the transfer of normal FRCs upregulated B cell lipid metabolism and increased GC numbers. In contrast, acetylcholine-deficient FRC transfer showed no effects on GC and autoreactive B cell responses. Systemic autoimmunity and immune complex to the kidney were also not affected by acetylcholine-deficient FRCs. Regarding acetylcholine-mediated intracellular signaling, they found that acetylcholine stimulation led to the release of calcium from the endoplasmic reticulum and calcium influx through the ORAI channel, driving FAO in B cells. “This study provides mechanistic insights to understand the pathogenesis of SLE that spleen FRCs contribute significantly to the development of autoreactive B cell response and systemic autoimmunity by producing neurotransmitter acetylcholine. Targeting cholinergic signaling could be the mechanism to normalize B cell metabolism and serve as therapeutic targets in humans with SLE,” remarks Yang.

Inositol‐Requiring Enzyme 1α–mediated Synthesis of Monounsaturated Fatty Acids As a Driver of B Cell Differentiation and Lupus‐like Autoimmune Disease

The Oxysterol Receptor EBI2 Links Innate and Adaptive Immunity to Limit IFN Response and Systemic Lupus Erythematosus

Association Between Type I Interferon and Depletion and Dysfunction of Endothelial Progenitor Cells in C57BL/6 Mice Deficient in Both Apolipoprotein E and Fas Ligand.

Targeting abnormal lipid metabolism of T cells for systemic lupus erythematosus treatment

Lipid Metabolism: Immune Regulation and Therapeutic Prospectives in Systemic Lupus Erythematosus

Integration of multi-omics analysis reveals metabolic alterations of B lymphocytes in systemic lupus erythematosus

USP18 induction regulates immunometabolism to attenuate M1 signal-polarized macrophages and enhance IL-4-polarized macrophages in systemic lupus erythematosus

The Oxysterol Receptor EBI2 Links Innate and Adaptive Immunity to Limit IFN Response and Systemic Lupus Erythematosus (Adv. Sci. 27/2023)

Sirtuin 1 overexpression contributes to the expansion of follicular helper T cells in systemic lupus erythematosus and may serve as an accessible therapeutic target

Cutting Edge: Intracellular IFN-β and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells

T Cell Homeostatic Proliferation Promotes a Redox State That Drives Metabolic and Epigenetic Upregulation of Inflammatory Pathways in Lupus

The Role of Sirtuin-1 in Immune Response and Systemic Lupus Erythematosus

Ligation of CD180 Inhibits IFN-α Signaling in a Lyn-PI3K-BTK-dependent Manner in B Cells

Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus

Inhibition of IRF5 hyperactivation protects from lupus onset and severity

Immunometabolic Mechanisms of LANCL2 in CD4+ T Cells and Phagocytes Provide Protection from Systemic Lupus Erythematosus

Acetylcholine Promotes Autoreactive B Cell Response

Lupus High-Density Lipoprotein Induces Proinflammatory Responses in Macrophages by Binding Lectin-Like Oxidised Low-Density Lipoprotein Receptor 1 and Failing to Promote Activating Transcription Factor 3 Activity

Dyslipidemia is Associated with Inflammation and Organ Involvement in Systemic Lupus Erythematosus.

Tlr9-Induced Mir-155 And Ets-1 Decrease Expression Of Cd1d On B Cells In Sle

An unconventional mechanism of IL-1β secretion that requires Type I IFN in lupus monocytes